AngioDynamics (FRA:UG2) Net Change in Cash : €-2.0 Mil (TTM As of Aug. 2024)

View and export this data going back to 2013. Start your Free Trial

What is AngioDynamics Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

AngioDynamics's Net Change in Cash for the three months ended in Aug. 2024 was €-19.1 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Aug. 2024 was €-2.0 Mil.

AngioDynamics Net Change in Cash Historical Data

The historical data trend for AngioDynamics's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AngioDynamics Net Change in Cash Chart

AngioDynamics Annual Data

Trend

May15

May16

May17

May18

May19

May20

May21

May22

May23

May24

Net Change in Cash

Get a 7-Day Free Trial

-158.83

-5.16

-18.29

14.53

29.08

AngioDynamics Quarterly Data
	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24
Net Change in Cash	Get a 7-Day Free Trial															11.89	3.06	16.27	-2.22	-19.09

AngioDynamics Net Change in Cash Calculation

AngioDynamics's Net Change in Cash for the fiscal year that ended in May. 2024 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	-26.046	+	114.438	+	-59.429	+	0.116
	=	29.1

AngioDynamics's Net Change in Cash for the quarter that ended in Aug. 2024

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= -16.555 + -2.181 + -0.462 + 0.105

= -19.1

Net Change in Cash for the trailing twelve months (TTM) ended in Aug. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-2.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AngioDynamics Net Change in Cash Related Terms
Thank you for viewing the detailed overview of AngioDynamics's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

AngioDynamics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AngioDynamics Inc (FRA:UG2) » Definitions » Net Change in Cash

Comparable Companies

OSUR SMTI UTMD INFU STXS ZJYL KRMD PDEX AKYA HBIO ISRG XPAR:EL BDX TSE:7741 XSWX:ALC RMD TSE:4543 OCSE:COLO B WST COO

Traded in Other Exchanges

ANGO:USA UG2:Germany

Address

14 Plaza Drive, Latham, NY, USA, 12110

Website

https://www.angiodynamics.com

AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.

AngioDynamics Headlines

No Headlines